BRPI0910931A2 - ciclopentanos substituídos terapêuticos - Google Patents
ciclopentanos substituídos terapêuticosInfo
- Publication number
- BRPI0910931A2 BRPI0910931A2 BRPI0910931A BRPI0910931A BRPI0910931A2 BR PI0910931 A2 BRPI0910931 A2 BR PI0910931A2 BR PI0910931 A BRPI0910931 A BR PI0910931A BR PI0910931 A BRPI0910931 A BR PI0910931A BR PI0910931 A2 BRPI0910931 A2 BR PI0910931A2
- Authority
- BR
- Brazil
- Prior art keywords
- substituted cyclopentanes
- therapeutic substituted
- therapeutic
- cyclopentanes
- substituted
- Prior art date
Links
- 150000001940 cyclopentanes Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3762508P | 2008-03-18 | 2008-03-18 | |
| US12/404,753 US7732443B2 (en) | 2008-03-18 | 2009-03-16 | Therapeutic substituted cyclopentanes |
| PCT/US2009/037355 WO2009117388A1 (en) | 2008-03-18 | 2009-03-17 | Therapeutic substituted cyclopentanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0910931A2 true BRPI0910931A2 (pt) | 2019-09-24 |
Family
ID=41089539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0910931A BRPI0910931A2 (pt) | 2008-03-18 | 2009-03-17 | ciclopentanos substituídos terapêuticos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7732443B2 (enExample) |
| EP (1) | EP2265576A1 (enExample) |
| JP (1) | JP2011515406A (enExample) |
| KR (1) | KR20100135264A (enExample) |
| CN (1) | CN102007098B (enExample) |
| AU (1) | AU2009225706B2 (enExample) |
| BR (1) | BRPI0910931A2 (enExample) |
| CA (1) | CA2718900A1 (enExample) |
| RU (1) | RU2501789C2 (enExample) |
| WO (1) | WO2009117388A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2728227A1 (en) * | 2008-05-09 | 2009-11-12 | Allergan, Inc. | Therapeutic cyclopentane derivatives |
| US8569349B2 (en) * | 2008-05-09 | 2013-10-29 | Allergan, Inc. | Therapeutic compounds |
| US9090595B2 (en) | 2012-08-27 | 2015-07-28 | Allergan, Inc. | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes |
| JP6270848B2 (ja) * | 2012-08-27 | 2018-01-31 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | ベータ−クロロシクロペンタンの親水性エステルプロドラッグの使用による角膜中央部肥厚の低下 |
| WO2015175075A1 (en) * | 2014-02-20 | 2015-11-19 | Allergan, Inc. | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes |
| US9340534B2 (en) * | 2014-07-25 | 2016-05-17 | Allergan, Inc. | Compounds and methods for treating ocular diseases |
| ES2757798T3 (es) | 2014-10-02 | 2020-04-30 | Allergan Inc | Profármacos de éster de gamma-lactamas y su uso |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) * | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4675182A (en) * | 1983-02-12 | 1987-06-23 | Bayer Aktiengesellschaft | Complexes of prostaglandins |
| US5462968A (en) * | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US5698598A (en) * | 1995-08-04 | 1997-12-16 | Allergan | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US6090847A (en) * | 1997-11-21 | 2000-07-18 | Allergan Sales, Inc. | EP2 -receptor agonists as neuroprotective agents for the eye |
| US6437146B1 (en) * | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| US6410591B1 (en) * | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| ES2246419T3 (es) * | 2001-11-05 | 2006-02-16 | Allergan, Inc. | Analogos de omega-cicloalquil-17-heteroaril-prostaglandina e2 como agonistas del receptor ep-2. |
| JP5319065B2 (ja) * | 2003-02-11 | 2013-10-16 | アラーガン インコーポレイテッド | 眼圧降下剤としての１０，１０−ジアルキルプロスタン酸誘導体 |
| TWI348386B (en) * | 2003-08-12 | 2011-09-11 | R Tech Ueno Ltd | Composition and method for promoting hair growth |
| US7091231B2 (en) * | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| US7427685B2 (en) * | 2005-12-06 | 2008-09-23 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| JP2011519939A (ja) * | 2008-05-09 | 2011-07-14 | アラーガン インコーポレイテッド | 治療用化合物 |
-
2009
- 2009-03-16 US US12/404,753 patent/US7732443B2/en not_active Expired - Fee Related
- 2009-03-17 AU AU2009225706A patent/AU2009225706B2/en not_active Expired - Fee Related
- 2009-03-17 KR KR1020107023241A patent/KR20100135264A/ko not_active Ceased
- 2009-03-17 JP JP2011500890A patent/JP2011515406A/ja active Pending
- 2009-03-17 BR BRPI0910931A patent/BRPI0910931A2/pt not_active IP Right Cessation
- 2009-03-17 EP EP09723041A patent/EP2265576A1/en not_active Withdrawn
- 2009-03-17 RU RU2010141793/04A patent/RU2501789C2/ru not_active IP Right Cessation
- 2009-03-17 CA CA2718900A patent/CA2718900A1/en not_active Abandoned
- 2009-03-17 WO PCT/US2009/037355 patent/WO2009117388A1/en not_active Ceased
- 2009-03-17 CN CN200980113565.8A patent/CN102007098B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009225706A1 (en) | 2009-09-24 |
| AU2009225706B2 (en) | 2014-07-31 |
| RU2501789C2 (ru) | 2013-12-20 |
| US20090239869A1 (en) | 2009-09-24 |
| US7732443B2 (en) | 2010-06-08 |
| CA2718900A1 (en) | 2009-09-24 |
| CN102007098A (zh) | 2011-04-06 |
| KR20100135264A (ko) | 2010-12-24 |
| CN102007098B (zh) | 2014-05-07 |
| JP2011515406A (ja) | 2011-05-19 |
| WO2009117388A1 (en) | 2009-09-24 |
| EP2265576A1 (en) | 2010-12-29 |
| RU2010141793A (ru) | 2012-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20240029I1 (fi) | lkodekinsuliini | |
| NO2025013I1 (no) | concizumab | |
| FIC20240037I1 (fi) | Fidanakogeenielaparvoveekki | |
| NL301152I2 (nl) | satralizumab | |
| NO2020045I1 (no) | Luspatercept | |
| FIC20190008I1 (fi) | Abemasiklibi | |
| NL300965I1 (nl) | Patisiran | |
| EP2320907A4 (en) | THERAPEUTIC COMPOUNDS | |
| EP2296593A4 (en) | MEDICAL HEAD COVER | |
| BRPI0916931A2 (pt) | agentes terapêuticos | |
| DK2370462T3 (da) | Glucagon-analoger | |
| DE602009000234D1 (de) | msignals | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| DK2340021T3 (da) | Substituerede pyrrolidin-2-carboxamider | |
| EP2368526A4 (en) | INSERTION TOOL FOR AN INTRAOCULAR LENS | |
| EP2268285A4 (en) | THERAPEUTIC COMPOUNDS | |
| DK2318650T3 (da) | Kompletteringsaggregat | |
| DE602008003970D1 (de) | Strahlstromkalibriersystem | |
| BRPI0907522A2 (pt) | biarlamidas | |
| BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| DE112009001946A5 (de) | Mobelauszugsführung | |
| BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas | |
| AT507449A3 (de) | Dämmstoffbefestiger |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |